INTC: TeraFab Hype Meets $0 Earnings Reality
Key Takeaways
- Intel's $25B TeraFab deal with Musk's companies is strategically significant but won't generate revenue until 2028-2029 at the earliest.
- The stock trades at $52.33 with negative trailing EPS of -$0.06 and 57x EV/EBITDA — turnaround pricing before the turnaround.
- Wait for the April 23 earnings report before committing capital — a post-earnings pullback offers better risk-reward than chasing near the 52-week high.
Intel trades at $52.33, up 196% from its 52-week low of $17.67 and within striking distance of its $54.60 high. The catalyst this week: Elon Musk's $25 billion TeraFab project chose Intel as its foundry partner, alongside SpaceX, Tesla, and xAI. The stock jumped 3% on the news alone.
Here's the problem nobody wants to discuss. Intel's trailing twelve-month EPS is negative $0.06. The company has posted net losses in three of the last four quarters. Revenue has stabilised around $13.5 billion per quarter — respectable, but flat. The market is pricing in a turnaround that hasn't happened yet, and the TeraFab deal, while headline-grabbing, won't move the needle for years.
The contrarian question isn't whether Intel's foundry business has potential. It clearly does. The question is whether a stock trading at 1.54x book value with negative earnings deserves to be treated like the turnaround is already complete.
The TeraFab Deal: Big Headlines, Distant Revenue
The TeraFab announcement sent Intel shares surging, and the optics are undeniably compelling. Musk's ecosystem — SpaceX, Tesla, xAI — wants to produce custom chips at scale, and Intel's foundry infrastructure is the vehicle. Reports also suggest advanced talks with Google and Amazon for AI chip packaging services.
But semiconductor foundry contracts take years to materialise into revenue. TSMC's Arizona fab, announced in 2020, won't reach volume production until 2025. Intel's 18A process node, the backbone of its foundry pitch, is still in qualification. TeraFab revenue is a 2028-2029 story at the earliest.
The market is pricing this deal as if the cheque has already cleared. Intel's market cap sits at $261 billion — roughly 19x trailing revenue. For a company burning cash on capex ($3.49 billion in Q4 alone, or $0.72 per share), that's a steep multiple to pay for a promise.
Earnings: The Losses Nobody Mentions
Intel's quarterly earnings tell a story the stock price ignores:
Q3's $0.90 EPS looks like a bright spot until you examine the $3.9 billion in "other income" that inflated the number — likely asset sales or one-time gains, not operational improvement. (See how free cash flow differs from earnings for why this matters.). Strip that out, and Q3 operating income was just $683 million on $13.7 billion in revenue, a 5% operating margin.
Q4 wasn't much better: $550 million operating income, 4% margin. Revenue of $13.67 billion was essentially flat quarter-over-quarter. The company is stabilising, not accelerating.
Full-year 2025 revenue totalled $52.85 billion with a combined net loss of $267 million. Intel eliminated its dividend entirely — a move that freed up cash but signals management's own uncertainty about near-term profitability.
Valuation: Paying Turnaround Prices for a Work-in-Progress
At $52.33, Intel trades at 1.54x price-to-book on a book value of $26.02 per share. That's not expensive in absolute terms, but context matters. The company's return on equity is essentially zero (-0.5% in Q4). You're paying a premium over book for a business that isn't generating returns on its equity.
The EV/EBITDA ratio paints a clearer picture. At 57x trailing EBITDA, Intel is priced like a high-growth tech stock, not a mature semiconductor manufacturer trying to reinvent itself. By comparison, TSMC trades around 15x EV/EBITDA with actually growing earnings.
Analyst estimates for 2028 project quarterly EPS of $0.40-$0.52 — meaningful improvement, but that's two full years away. At the midpoint of those estimates ($1.80 annualised), Intel would trade at roughly 29x forward 2028 earnings. Not cheap for a company that needs everything to go right.
Financial Health: Cash Rich, Capex Heavy
Intel's balance sheet isn't the disaster some bears claim. Cash per share sits at $7.71, the current ratio is a comfortable 2.02, and total debt-to-equity is 0.41. The company can fund its transformation without an immediate liquidity crisis.
The concern is capital intensity. Intel spent $3.49 billion on capex in Q4, consuming 81% of operating cash flow. Free cash flow was a thin $0.16 per share. The foundry buildout — the very strategy the market is rewarding — requires sustained heavy spending that will suppress free cash flow for years.
Net debt-to-EBITDA of 8.9x is elevated. If EBITDA doesn't expand materially, Intel's leverage becomes a genuine constraint on shareholder returns. No dividend, no buybacks, and any stumble in the foundry ramp could force dilutive capital raises.
The Bull Case Isn't Wrong — It's Just Priced In
Intel's foundry strategy makes industrial sense. The U.S. government wants domestic chip manufacturing. CHIPS Act subsidies are flowing. Major tech companies need foundry alternatives to reduce TSMC concentration risk. Intel has the fabs, the IP, and the scale.
The problem is timing and execution. CEO Lip-Bu Tan inherited a company that failed its foundry pivot under Pat Gelsinger. The 18A node must succeed — not just technically, but commercially. One delay, one yield issue, and the entire narrative collapses.
With earnings due April 23, the next two weeks will test whether the stock can hold these levels. The market wants to hear progress on foundry customer wins, 18A yield data, and a credible path to positive EPS. Anything less, and a stock trading near its 52-week high on negative earnings becomes vulnerable to a sharp correction.
Conclusion
Intel's TeraFab partnership with Musk's companies is a genuine strategic win, but the stock has already priced in years of execution that hasn't happened. At $52.33 with negative trailing earnings and 57x EV/EBITDA, the risk-reward is skewed against new buyers.
The trade here is patience. Wait for the April 23 earnings report. If Intel can demonstrate positive operating leverage and credible 18A progress, there's a buying opportunity on any post-earnings pullback. Chasing a near-52-week-high stock with no earnings is how portfolios get damaged. The turnaround thesis has legs — but the price already reflects the destination, not the journey.
Frequently Asked Questions
Sources & References
www.proactiveinvestors.com
247wallst.com
invezz.com
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.